» Authors » Alfonso Jurado-Roman

Alfonso Jurado-Roman

Explore the profile of Alfonso Jurado-Roman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 110
Citations 294
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lara-Garcia A, Jurado-Roman A, Marquez D, Garcia A, Valero S, Moreno R
Rev Esp Cardiol (Engl Ed) . 2025 Mar; PMID: 40049371
No abstract available.
2.
Negreira-Caamano M, Diez-Delhoyo F, Cepas-Guillen P, Lopez-Lluva M, Jurado-Roman A, Bazal-Chacon P, et al.
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39954993
Introduction And Objectives: Arrhythmias such as atrial fibrillation and atrial flutter (AF/AFl) complicate the management of patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). The aim of this study was...
3.
Machado G, Negreira-Caamano M, Tebar D, Marquez D, Moura Schmidt M, Pagnoncelli A, et al.
Crit Pathw Cardiol . 2025 Feb; 24(1):e0371. PMID: 39950761
Background: Patients with long coronary lesions undergoing primary percutaneous coronary intervention (pPCI) have higher rates of adverse clinical events. Both stent length and stent overlap are associated with worse outcomes;...
4.
Jurado-Roman A, Gomez-Menchero A, Rivero-Santana B, Amat-Santos I, Jimenez-Valero S, Caballero-Borrego J, et al.
JACC Cardiovasc Interv . 2025 Feb; 18(5):606-618. PMID: 39918495
Background: Coronary calcification negatively affects the safety and effectiveness of percutaneous coronary intervention. There is a lack of randomized comparisons among different plaque modification techniques. Objectives: The aim of this...
5.
Gallo I, Azzalini L, Gonzalez-Manzanares R, Moscardelli S, Jurado-Roman A, Maestre L, et al.
Catheter Cardiovasc Interv . 2025 Jan; 105(4):883-890. PMID: 39777977
Background: The therapeutic management of patients with multivessel disease and severe left ventricular dysfunction is complex and controversial. Aims: The aim of this study was to analyze the clinical outcomes...
6.
Costa F, Jurado-Roman A, Carciotto G, Becerra-Munoz V, Marquez D, Gotzinger F, et al.
J Clin Med . 2025 Jan; 13(24. PMID: 39768703
Pulmonary embolism (PE) is a life-threatening medical condition caused by the thrombotic occlusion of one or more branches of the lung vasculature, which represents the third most common cause of...
7.
8.
Cobarro L, Jimenez-Valero S, Gutierrez-Larraya F, Merino C, Meras P, Ruiz-Cantador J, et al.
Int J Cardiol Congenit Heart Dis . 2024 Dec; 17:100518. PMID: 39711775
Background: Obstructive complications in the Fontan circulation pose significant risks to affected patients. Traditional management strategies may be insufficient, necessitating innovative treatment approaches. This case report discusses the use of...
9.
Salinas P, Alvarez A, Jorge Perez P, Vazquez-Alvarez M, Jurado-Roman A, Juarez M, et al.
Rev Esp Cardiol (Engl Ed) . 2024 Nov; 78(3):239-251. PMID: 39566820
Pulmonary embolism (PE) is the leading cause of hospital death and the third most frequent cause of cardiovascular mortality. Traditionally, treatment options have included anticoagulation, thrombolysis, or surgery; however, catheter-directed...
10.
Garcia-Escobar A, Jimenez-Valero S, Galeote G, Jurado-Roman A, Cabrera J, Moreno R
Future Cardiol . 2024 Nov; 20(15-16):823-826. PMID: 39560006
Bicuspid aortic valve (BAV) is one of the most common congenital valvular heart diseases occurring in 0.5-2% of the general population, in 2-6% of patients with severe aortic stenosis (AS)...